Glenn Gregory M

Novavax, Inc.

President, R&D

Avg. Two Year Performance

88% Avg. Purchase Return 37% Compound

2% Avg. Sale Return 1% Compound

Holdings: 18.34K shares

Last Three Months: 27-Aug-24 -- 26-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

27-Nov-22 -- 26-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions